研報掘金丨國聯民生:維持賽力斯“買入”評級,看好公司新車銷量
國聯民生證券研報指出,賽力斯(601127.SH)5月實現批發銷量4.42萬輛,同比+14.30%,環比+23.53%。其中1-5月問界M9 累計銷量5.05萬輛,累計同比+19.46%。新能源銷量快速回升,開啓增長新週期。2025年3月20日,2025款問界M9正式上市,僅64天大定訂單量即突破6萬臺,延續了其在50萬級市場的現象級熱度。M8/M9引領豪華SUV市場,新車有望推動公司銷量再上新臺階。隨着M8產能爬坡以及後續新車上市,看好公司新車銷量,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.